SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '476'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1E06_B_IPBB600_0 (ODORANT-BINDINGPROTEIN) |
4b2q | ATP SYNTHASE SUBUNITBETA, MITOCHONDRIAL (Saccharomycescerevisiae) | 4 / 4 | ILE D 344MET D 459VAL D 165GLY D 343 | NoneNoneADP D1476 (-4.2A)None | 1.14A | 1e06B-4b2qD:undetectable | 1e06B-4b2qD:16.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EI6_A_PPFA410_1 (PHOSPHONOACETATEHYDROLASE) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 4 / 5 | ASP A 304HIS A 308HIS A 347HIS A 435 | ZN A1475 ( 2.0A) ZN A1475 ( 3.2A) ZN A1476 ( 3.1A) ZN A1475 ( 3.2A) | 0.38A | 1ei6A-2x98A:15.9 | 1ei6A-2x98A:23.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EI6_C_PPFC413_1 (PHOSPHONOACETATEHYDROLASE) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 5 / 8 | ASP A 56ASP A 304HIS A 308HIS A 347HIS A 435 | ZN A1476 (-2.2A) ZN A1475 ( 2.0A) ZN A1475 ( 3.2A) ZN A1476 ( 3.1A) ZN A1475 ( 3.2A) | 0.46A | 1ei6C-2x98A:15.8 | 1ei6C-2x98A:23.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_A_ACTA3003_0 (BETA-CARBONICANHYDRASE) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 4 / 8 | GLN A 169ASP A 216HIS A 241GLY A 79 | NoneNoneNoneIF6 A1476 (-3.1A) | 0.96A | 1ekjA-5g0qA:undetectable1ekjB-5g0qA:undetectable | 1ekjA-5g0qA:18.951ekjB-5g0qA:18.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FM6_X_BRLX504_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2euh | NADP DEPENDENT NONPHOSPHORYLATINGGLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (Streptococcusmutans) | 5 / 12 | ILE A 454PHE A 444GLY A 456SER A 162MET A 248 | NoneNAP A 476 (-4.1A)NoneNoneNone | 1.29A | 1fm6X-2euhA:undetectable | 1fm6X-2euhA:21.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1K2R_A_H4BA1760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.28A | 1k2rA-5fjnA:undetectable1k2rB-5fjnA:undetectable | 1k2rA-5fjnA:24.551k2rB-5fjnA:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1K2R_B_H4BB2760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 1k2rA-5fjnA:undetectable1k2rB-5fjnA:undetectable | 1k2rA-5fjnA:24.551k2rB-5fjnA:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1K2S_A_H4BA1760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 1k2sA-5fjnA:undetectable1k2sB-5fjnA:undetectable | 1k2sA-5fjnA:24.551k2sB-5fjnA:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1K2S_B_H4BB2760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.35A | 1k2sA-5fjnA:undetectable1k2sB-5fjnA:undetectable | 1k2sA-5fjnA:24.551k2sB-5fjnA:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1K2U_A_H4BA1760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.35A | 1k2uA-5fjnA:undetectable1k2uB-5fjnA:undetectable | 1k2uA-5fjnA:24.551k2uB-5fjnA:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1K2U_B_H4BB2760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.35A | 1k2uA-5fjnA:undetectable1k2uB-5fjnA:undetectable | 1k2uA-5fjnA:24.551k2uB-5fjnA:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1LZX_A_H4BA760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 1lzxA-5fjnA:undetectable1lzxB-5fjnA:undetectable | 1lzxA-5fjnA:24.551lzxB-5fjnA:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1LZX_B_H4BB1760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.34A | 1lzxA-5fjnA:undetectable1lzxB-5fjnA:undetectable | 1lzxA-5fjnA:24.551lzxB-5fjnA:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1LZZ_B_H4BB1760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 1lzzA-5fjnA:undetectable1lzzB-5fjnA:undetectable | 1lzzA-5fjnA:24.551lzzB-5fjnA:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1M00_A_H4BA760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 1m00A-5fjnA:undetectable1m00B-5fjnA:undetectable | 1m00A-5fjnA:24.551m00B-5fjnA:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MMW_A_H4BA1760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 1mmwA-5fjnA:undetectable1mmwB-5fjnA:undetectable | 1mmwA-5fjnA:24.551mmwB-5fjnA:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MMW_B_H4BB2760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 1mmwA-5fjnA:undetectable1mmwB-5fjnA:undetectable | 1mmwA-5fjnA:24.551mmwB-5fjnA:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N2X_B_SAMB402_0 (S-ADENOSYL-METHYLTRANSFERASE MRAW) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 6 / 12 | GLY A 103GLY A 329GLY A 328HIS A 327TYR A 84GLY A 107 | NoneNoneNoneIF6 A1476 (-4.2A)NoneNone | 1.25A | 1n2xB-5g0qA:undetectable | 1n2xB-5g0qA:20.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OM5_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 8 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 1om5A-5fjnA:undetectable1om5B-5fjnA:undetectable | 1om5A-5fjnA:23.521om5B-5fjnA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6H_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.29A | 1p6hA-5fjnA:undetectable1p6hB-5fjnA:undetectable | 1p6hA-5fjnA:23.521p6hB-5fjnA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6H_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.35A | 1p6hA-5fjnA:undetectable1p6hB-5fjnA:undetectable | 1p6hA-5fjnA:23.521p6hB-5fjnA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6I_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.27A | 1p6iA-5fjnA:undetectable1p6iB-5fjnA:undetectable | 1p6iA-5fjnA:23.521p6iB-5fjnA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6I_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 1p6iA-5fjnA:undetectable1p6iB-5fjnA:undetectable | 1p6iA-5fjnA:23.521p6iB-5fjnA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6J_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 1p6jA-5fjnA:undetectable1p6jB-5fjnA:undetectable | 1p6jA-5fjnA:23.521p6jB-5fjnA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6K_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.34A | 1p6kA-5fjnA:undetectable1p6kB-5fjnA:undetectable | 1p6kA-5fjnA:23.521p6kB-5fjnA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QW6_A_H4BA901_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 3 / 3 | ARG A 316VAL A 438TRP A 439 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 0.96A | 1qw6A-5fjnA:undetectable | 1qw6A-5fjnA:23.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QWC_A_H4BA901_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 3 / 3 | ARG A 316VAL A 438TRP A 439 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 0.97A | 1qwcA-5fjnA:undetectable | 1qwcA-5fjnA:23.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1R30_A_SAMA501_0 (BIOTIN SYNTHASE) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 5 / 12 | GLY A 307ASP A 346ILE A 54LEU A 297VAL A 298 | None ZN A1476 (-2.3A)NoneNoneNone | 1.17A | 1r30A-2x98A:undetectable | 1r30A-2x98A:22.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RQJ_A_RISA901_1 (GERANYLTRANSTRANSFERASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.72A | 1rqjA-4jzxA:31.0 | 1rqjA-4jzxA:26.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RQJ_A_RISA901_1 (GERANYLTRANSTRANSFERASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.46A | 1rqjA-4jzxA:31.0 | 1rqjA-4jzxA:26.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RQJ_B_RISB903_1 (GERANYLTRANSTRANSFERASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.74A | 1rqjB-4jzxA:31.0 | 1rqjB-4jzxA:26.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RQJ_B_RISB903_1 (GERANYLTRANSTRANSFERASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.45A | 1rqjB-4jzxA:31.0 | 1rqjB-4jzxA:26.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS6_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.27A | 1rs6A-5fjnA:undetectable1rs6B-5fjnA:undetectable | 1rs6A-5fjnA:23.521rs6B-5fjnA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS6_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 8 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 1rs6A-5fjnA:undetectable1rs6B-5fjnA:undetectable | 1rs6A-5fjnA:23.521rs6B-5fjnA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS7_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.26A | 1rs7A-5fjnA:undetectable1rs7B-5fjnA:undetectable | 1rs7A-5fjnA:23.521rs7B-5fjnA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS7_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 1rs7A-5fjnA:undetectable1rs7B-5fjnA:undetectable | 1rs7A-5fjnA:23.521rs7B-5fjnA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1T03_P_TFOP822_1 (POL POLYPROTEINSYNTHETICOLIGONUCLEOTIDEPRIMER) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 4 / 7 | MET A 101ASP A 102ASP A 99LYS A 264 | None CA A 403 (-2.5A)None476 A 402 (-2.9A) | 1.31A | 1t03A-4jzxA:undetectable | 1t03A-4jzxA:21.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VAG_A_H4BA901_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 3 / 3 | ARG A 316VAL A 438TRP A 439 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 0.97A | 1vagA-5fjnA:undetectable | 1vagA-5fjnA:23.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Y7I_A_SALA502_1 (SALICYLICACID-BINDING PROTEIN2) |
5mmi | 50S RIBOSOMALPROTEIN L34,CHLOROPLASTIC (Spinaciaoleracea) | 3 / 3 | LEU 3 108HIS 3 112LYS 3 141 | U A 697 ( 4.4A) U A 476 ( 3.9A) U A 476 ( 3.4A) | 0.92A | 1y7iA-5mmi3:undetectable | 1y7iA-5mmi3:19.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YHL_A_RISA1400_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 11 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.13A | 1yhlA-4jzxA:54.0 | 1yhlA-4jzxA:63.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YHL_A_RISA1400_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.63A | 1yhlA-4jzxA:54.0 | 1yhlA-4jzxA:63.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YHL_A_RISA1400_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 10 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208TYR A 211GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)NoneIPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.44A | 1yhlA-4jzxA:54.0 | 1yhlA-4jzxA:63.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YQ7_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHETASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 11 | LEU A 95ARG A 107THR A 212TYR A 211LYS A 264 | None476 A 402 (-2.9A)IPE A 401 ( 4.6A)None476 A 402 (-2.9A) | 1.45A | 1yq7A-4jzxA:43.7 | 1yq7A-4jzxA:37.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YQ7_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHETASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 10 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.71A | 1yq7A-4jzxA:43.7 | 1yq7A-4jzxA:37.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YQ7_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHETASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 10 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208TYR A 211GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)NoneIPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.53A | 1yq7A-4jzxA:43.7 | 1yq7A-4jzxA:37.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YV5_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHETASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.59A | 1yv5A-4jzxA:44.0 | 1yv5A-4jzxA:37.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YV5_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHETASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.37A | 1yv5A-4jzxA:44.0 | 1yv5A-4jzxA:37.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z9H_A_IMNA379_1 (MEMBRANE-ASSOCIATEDPROSTAGLANDIN ESYNTHASE-2) |
2pbj | PROSTAGLANDIN ESYNTHASE 2 (Macacafascicularis) | 12 / 12 | TYR A 107THR A 109CYH A 110PRO A 111PRO A 134VAL A 250TYR A 251SER A 260TYR A 263ILE A 264VAL A 343LEU A 347 | HEM A 476 (-4.0A)HEM A 476 (-4.1A)GSH A 477 (-3.3A)HEM A 476 (-4.2A)HEM A 476 (-4.1A)NoneNoneNoneNoneHEM A 476 (-4.7A)NoneNone | 0.31A | 1z9hA-2pbjA:44.7 | 1z9hA-2pbjA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z9H_B_IMNB381_1 (MEMBRANE-ASSOCIATEDPROSTAGLANDIN ESYNTHASE-2) |
2pbj | PROSTAGLANDIN ESYNTHASE 2 (Macacafascicularis) | 12 / 12 | TYR A 107THR A 109CYH A 110PRO A 111PRO A 134VAL A 250TYR A 251SER A 260TYR A 263ILE A 264VAL A 343LEU A 347 | HEM A 476 (-4.0A)HEM A 476 (-4.1A)GSH A 477 (-3.3A)HEM A 476 (-4.2A)HEM A 476 (-4.1A)NoneNoneNoneNoneHEM A 476 (-4.7A)NoneNone | 0.31A | 1z9hB-2pbjA:44.7 | 1z9hB-2pbjA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z9H_C_IMNC379_1 (MEMBRANE-ASSOCIATEDPROSTAGLANDIN ESYNTHASE-2) |
2pbj | PROSTAGLANDIN ESYNTHASE 2 (Macacafascicularis) | 12 / 12 | TYR A 107THR A 109CYH A 110PRO A 111PRO A 134VAL A 250TYR A 251SER A 260TYR A 263ILE A 264VAL A 343LEU A 347 | HEM A 476 (-4.0A)HEM A 476 (-4.1A)GSH A 477 (-3.3A)HEM A 476 (-4.2A)HEM A 476 (-4.1A)NoneNoneNoneNoneHEM A 476 (-4.7A)NoneNone | 0.31A | 1z9hC-2pbjA:44.6 | 1z9hC-2pbjA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z9H_D_IMND476_1 (MEMBRANE-ASSOCIATEDPROSTAGLANDIN ESYNTHASE-2) |
2pbj | PROSTAGLANDIN ESYNTHASE 2 (Macacafascicularis) | 12 / 12 | THR A 109CYH A 110PRO A 111PRO A 134ILE A 246VAL A 250TYR A 251SER A 260TYR A 263ILE A 264VAL A 343LEU A 347 | HEM A 476 (-4.1A)GSH A 477 (-3.3A)HEM A 476 (-4.2A)HEM A 476 (-4.1A)HEM A 476 ( 3.8A)NoneNoneNoneNoneHEM A 476 (-4.7A)NoneNone | 0.35A | 1z9hD-2pbjA:44.7 | 1z9hD-2pbjA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZVI_A_H4BA901_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 3 / 3 | ARG A 316VAL A 438TRP A 439 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 0.93A | 1zviA-5fjnA:undetectable | 1zviA-5fjnA:23.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZVL_A_H4BA900_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.30A | 1zvlA-5fjnA:undetectable1zvlB-5fjnA:undetectable | 1zvlA-5fjnA:23.811zvlB-5fjnA:23.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZVL_B_H4BB920_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.16A | 1zvlA-5fjnA:undetectable1zvlB-5fjnA:undetectable | 1zvlA-5fjnA:23.811zvlB-5fjnA:23.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZW5_A_ZOLA901_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.60A | 1zw5A-4jzxA:45.1 | 1zw5A-4jzxA:38.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZW5_A_ZOLA901_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 9 | ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.42A | 1zw5A-4jzxA:45.1 | 1zw5A-4jzxA:38.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZZQ_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.35A | 1zzqA-5fjnA:undetectable1zzqB-5fjnA:undetectable | 1zzqA-5fjnA:24.301zzqB-5fjnA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2E91_A_ZOLA901_1 (GERANYLGERANYLPYROPHOSPHATESYNTHETASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A) | 0.70A | 2e91A-4jzxA:24.5 | 2e91A-4jzxA:21.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2E91_A_ZOLA901_1 (GERANYLGERANYLPYROPHOSPHATESYNTHETASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167THR A 163 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-4.8A) | 1.38A | 2e91A-4jzxA:24.5 | 2e91A-4jzxA:21.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2E91_A_ZOLA901_1 (GERANYLGERANYLPYROPHOSPHATESYNTHETASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A) | 0.52A | 2e91A-4jzxA:24.5 | 2e91A-4jzxA:21.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2E91_B_ZOLB902_1 (GERANYLGERANYLPYROPHOSPHATESYNTHETASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207THR A 208GLN A 247ASP A 250 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A) | 0.66A | 2e91B-4jzxA:23.7 | 2e91B-4jzxA:21.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2E91_B_ZOLB902_1 (GERANYLGERANYLPYROPHOSPHATESYNTHETASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167THR A 163 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-4.8A) | 1.45A | 2e91B-4jzxA:23.7 | 2e91B-4jzxA:21.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F89_F_210F9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.07A | 2f89F-4jzxA:46.2 | 2f89F-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F89_F_210F9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 9 | ASP A 98ASP A 102ARG A 107LYS A 207THR A 208TYR A 211GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)NoneIPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.29A | 2f89F-4jzxA:46.2 | 2f89F-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F8C_F_ZOLF9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 11 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.15A | 2f8cF-4jzxA:45.1 | 2f8cF-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F8C_F_ZOLF9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 11 | LEU A 95ARG A 107THR A 212TYR A 211LYS A 264 | None476 A 402 (-2.9A)IPE A 401 ( 4.6A)None476 A 402 (-2.9A) | 1.42A | 2f8cF-4jzxA:45.1 | 2f8cF-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F8C_F_ZOLF9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.59A | 2f8cF-4jzxA:45.1 | 2f8cF-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F8C_F_ZOLF9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 10 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208TYR A 211GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)NoneIPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.38A | 2f8cF-4jzxA:45.1 | 2f8cF-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F8Z_F_ZOLF5001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.16A | 2f8zF-4jzxA:45.8 | 2f8zF-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F8Z_F_ZOLF5001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 10 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.60A | 2f8zF-4jzxA:45.8 | 2f8zF-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F94_F_BFQF9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 12 / 12 | LEU A 95ASP A 98ASP A 102ARG A 107THR A 163GLN A 167LYS A 207THR A 208TYR A 211GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-4.8A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)NoneIPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.37A | 2f94F-4jzxA:44.8 | 2f94F-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F9K_F_ZOLF9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.16A | 2f9kF-4jzxA:44.9 | 2f9kF-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F9K_F_ZOLF9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.63A | 2f9kF-4jzxA:44.9 | 2f9kF-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F9K_F_ZOLF9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.42A | 2f9kF-4jzxA:44.9 | 2f9kF-4jzxA:38.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6H_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 8 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 2g6hA-5fjnA:undetectable2g6hB-5fjnA:undetectable | 2g6hA-5fjnA:24.302g6hB-5fjnA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6H_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 2g6hA-5fjnA:undetectable2g6hB-5fjnA:undetectable | 2g6hA-5fjnA:24.302g6hB-5fjnA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6K_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 2g6kA-5fjnA:undetectable2g6kB-5fjnA:undetectable | 2g6kA-5fjnA:24.302g6kB-5fjnA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6K_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 2g6kA-5fjnA:undetectable2g6kB-5fjnA:undetectable | 2g6kA-5fjnA:24.302g6kB-5fjnA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6M_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.35A | 2g6mA-5fjnA:undetectable2g6mB-5fjnA:undetectable | 2g6mA-5fjnA:24.302g6mB-5fjnA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6M_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 2g6mA-5fjnA:undetectable2g6mB-5fjnA:undetectable | 2g6mA-5fjnA:24.302g6mB-5fjnA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HX3_A_H4BA760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 2hx3A-5fjnA:undetectable2hx3B-5fjnA:undetectable | 2hx3A-5fjnA:23.272hx3B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HX3_B_H4BB760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.27A | 2hx3A-5fjnA:undetectable2hx3B-5fjnA:undetectable | 2hx3A-5fjnA:23.272hx3B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HX4_A_H4BA760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.33A | 2hx4A-5fjnA:undetectable2hx4B-5fjnA:undetectable | 2hx4A-5fjnA:23.272hx4B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HX4_B_H4BB760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 2hx4A-5fjnA:undetectable2hx4B-5fjnA:undetectable | 2hx4A-5fjnA:23.272hx4B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2J2P_C_SC2C1289_1 (FICOLIN-2) |
2euh | NADP DEPENDENT NONPHOSPHORYLATINGGLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (Streptococcusmutans) | 4 / 6 | SER A 401SER A 450LEU A 405GLY A 404 | NoneNoneNAP A 476 ( 4.7A)None | 0.98A | 2j2pA-2euhA:undetectable2j2pC-2euhA:undetectable | 2j2pA-2euhA:18.052j2pC-2euhA:18.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2J2P_F_SC2F1289_1 (FICOLIN-2) |
2euh | NADP DEPENDENT NONPHOSPHORYLATINGGLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (Streptococcusmutans) | 4 / 6 | SER A 401SER A 450LEU A 405GLY A 404 | NoneNoneNAP A 476 ( 4.7A)None | 0.96A | 2j2pD-2euhA:undetectable2j2pF-2euhA:undetectable | 2j2pD-2euhA:18.052j2pF-2euhA:18.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2O1O_A_RISA400_1 (PUTATIVE FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) | 0.76A | 2o1oA-4jzxA:37.2 | 2o1oA-4jzxA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2O1O_A_RISA400_1 (PUTATIVE FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) | 0.53A | 2o1oA-4jzxA:37.2 | 2o1oA-4jzxA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2O1O_A_RISA400_1 (PUTATIVE FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | LEU A 95ASP A 98ASP A 102GLN A 167THR A 163 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-3.5A)476 A 402 (-4.8A) | 1.48A | 2o1oA-4jzxA:37.2 | 2o1oA-4jzxA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2O1O_B_RISB400_1 (PUTATIVE FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 6 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) | 0.75A | 2o1oB-4jzxA:37.7 | 2o1oB-4jzxA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2O1O_B_RISB400_1 (PUTATIVE FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) | 0.64A | 2o1oB-4jzxA:37.7 | 2o1oB-4jzxA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2O4N_A_TPVA300_2 (PROTEASE) |
2euh | NADP DEPENDENT NONPHOSPHORYLATINGGLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (Streptococcusmutans) | 4 / 8 | LEU A 148ILE A 247GLY A 235ILE A 234 | NoneNoneNoneNAP A 476 (-3.8A) | 0.66A | 2o4nB-2euhA:undetectable | 2o4nB-2euhA:12.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q58_A_ZOLA1_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 98ASP A 102GLN A 167GLN A 247ASP A 251 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-3.5A)IPE A 401 (-3.7A)None | 0.84A | 2q58A-4jzxA:36.9 | 2q58A-4jzxA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q58_A_ZOLA1_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 98ASP A 102LYS A 207GLN A 247ASP A 250 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A) | 1.48A | 2q58A-4jzxA:36.9 | 2q58A-4jzxA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q58_A_ZOLA1_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 251 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A)None | 0.82A | 2q58A-4jzxA:36.9 | 2q58A-4jzxA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q58_B_ZOLB2_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) | 0.79A | 2q58B-4jzxA:37.1 | 2q58B-4jzxA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q58_B_ZOLB2_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 6 / 9 | ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) | 0.65A | 2q58B-4jzxA:37.1 | 2q58B-4jzxA:25.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QIS_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHETASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.14A | 2qisA-4jzxA:44.5 | 2qisA-4jzxA:36.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QIS_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHETASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.62A | 2qisA-4jzxA:44.5 | 2qisA-4jzxA:36.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VUF_B_FUAB2002_1 (SERUM ALBUMIN) |
3pm9 | PUTATIVEOXIDOREDUCTASE (Rhodopseudomonaspalustris) | 4 / 9 | ILE A 215VAL A 63CYH A 67LYS A 68 | FAD A 476 (-4.6A)NoneNoneNone | 0.94A | 2vufB-3pm9A:undetectable | 2vufB-3pm9A:22.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZW9_A_SAMA801_0 (LEUCINE CARBOXYLMETHYLTRANSFERASE 2) |
3pm9 | PUTATIVEOXIDOREDUCTASE (Rhodopseudomonaspalustris) | 5 / 12 | ILE A 468ASN A 470GLY A 214GLY A 211LEU A 181 | NoneFAD A 476 (-4.0A)NoneFAD A 476 (-3.2A)None | 0.98A | 2zw9A-3pm9A:undetectable | 2zw9A-3pm9A:20.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AF0_A_PAUA314_0 (PANTOTHENATE KINASE) |
1x9q | 4M5.3ANTI-FLUORESCEINSINGLE CHAINANTIBODY FRAGMENT (Homosapiens) | 5 / 8 | ASP A 101LEU A 56LYS A 58GLY A 103TYR A 105 | ACT A1476 (-4.1A)NoneACT A1476 (-3.0A)NoneNone | 1.50A | 3af0A-1x9qA:undetectable | 3af0A-1x9qA:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B3M_A_H4BA760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.35A | 3b3mA-5fjnA:undetectable3b3mB-5fjnA:undetectable | 3b3mA-5fjnA:23.273b3mB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B3M_B_H4BB760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 3b3mA-5fjnA:undetectable3b3mB-5fjnA:undetectable | 3b3mA-5fjnA:23.273b3mB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B3N_B_H4BB760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.34A | 3b3nA-5fjnA:undetectable3b3nB-5fjnA:undetectable | 3b3nA-5fjnA:23.273b3nB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B3O_B_H4BB760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 3b3oA-5fjnA:undetectable3b3oB-5fjnA:undetectable | 3b3oA-5fjnA:23.273b3oB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B3P_A_H4BA760_1 (NITRIC-OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 3b3pA-5fjnA:undetectable3b3pB-5fjnA:undetectable | 3b3pA-5fjnA:23.273b3pB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3C0Z_B_SHHB301_1 (HISTONE DEACETYLASE7A) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 4 / 8 | HIS A 435HIS A 308ASP A 56GLY A 57 | ZN A1475 ( 3.2A) ZN A1475 ( 3.2A) ZN A1476 (-2.2A)None | 0.87A | 3c0zB-2x98A:undetectable | 3c0zB-2x98A:23.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DQR_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.26A | 3dqrA-5fjnA:undetectable3dqrB-5fjnA:undetectable | 3dqrA-5fjnA:23.543dqrB-5fjnA:23.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EZ3_A_ZOLA397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.08A | 3ez3A-4jzxA:44.6 | 3ez3A-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EZ3_A_ZOLA397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.83A | 3ez3A-4jzxA:44.6 | 3ez3A-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EZ3_A_ZOLA397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 9 | ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.60A | 3ez3A-4jzxA:44.6 | 3ez3A-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EZ3_B_ZOLB397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.06A | 3ez3B-4jzxA:44.0 | 3ez3B-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EZ3_B_ZOLB397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.71A | 3ez3B-4jzxA:44.0 | 3ez3B-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EZ3_B_ZOLB397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 9 | ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.49A | 3ez3B-4jzxA:44.0 | 3ez3B-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EZ3_C_ZOLC397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.05A | 3ez3C-4jzxA:44.6 | 3ez3C-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EZ3_C_ZOLC397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 6 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.74A | 3ez3C-4jzxA:44.6 | 3ez3C-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EZ3_C_ZOLC397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 9 | ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.62A | 3ez3C-4jzxA:44.6 | 3ez3C-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EZ3_D_ZOLD397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.13A | 3ez3D-4jzxA:43.7 | 3ez3D-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EZ3_D_ZOLD397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.72A | 3ez3D-4jzxA:43.7 | 3ez3D-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3EZ3_D_ZOLD397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.46A | 3ez3D-4jzxA:43.7 | 3ez3D-4jzxA:33.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FC5_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.29A | 3fc5A-5fjnA:undetectable3fc5B-5fjnA:undetectable | 3fc5A-5fjnA:23.463fc5B-5fjnA:23.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FC5_B_H4BB761_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 3fc5A-5fjnA:undetectable3fc5B-5fjnA:undetectable | 3fc5A-5fjnA:23.463fc5B-5fjnA:23.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FI0_P_TRPP1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 4 / 7 | GLY A 345HIS A 347ASP A 56GLN A 62 | None ZN A1476 ( 3.1A) ZN A1476 (-2.2A)None | 0.93A | 3fi0P-2x98A:undetectable | 3fi0P-2x98A:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GN0_A_DMOA551_1 (ARGINASE-1) |
3nxl | GLUCARATEDEHYDRATASE (Burkholderialata) | 5 / 9 | HIS A 359ASP A 386HIS A 388ASP A 255GLU A 280 | MG A 476 ( 4.5A)NoneCO3 A 477 (-4.0A) MG A 476 (-2.8A) MG A 476 (-3.3A) | 1.49A | 3gn0A-3nxlA:undetectable | 3gn0A-3nxlA:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HSO_B_H4BB1760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 3hsoA-5fjnA:undetectable3hsoB-5fjnA:undetectable | 3hsoA-5fjnA:23.273hsoB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HSP_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 3hspA-5fjnA:undetectable3hspB-5fjnA:undetectable | 3hspA-5fjnA:23.273hspB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HSP_B_H4BB1760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 3hspA-5fjnA:undetectable3hspB-5fjnA:undetectable | 3hspA-5fjnA:23.273hspB-5fjnA:23.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IBA_A_ZOLA901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 10 | ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.74A | 3ibaA-4jzxA:53.8 | 3ibaA-4jzxA:63.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IBA_A_ZOLA901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | ASP A 98ASP A 102ARG A 107LYS A 207THR A 208TYR A 211GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)NoneIPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.50A | 3ibaA-4jzxA:53.8 | 3ibaA-4jzxA:63.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT3_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 3jt3A-5fjnA:undetectable3jt3B-5fjnA:undetectable | 3jt3A-5fjnA:23.273jt3B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT4_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.33A | 3jt4A-5fjnA:undetectable3jt4B-5fjnA:undetectable | 3jt4A-5fjnA:23.273jt4B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT4_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.35A | 3jt4A-5fjnA:undetectable3jt4B-5fjnA:undetectable | 3jt4A-5fjnA:23.273jt4B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT5_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.28A | 3jt5A-5fjnA:undetectable3jt5B-5fjnA:undetectable | 3jt5A-5fjnA:23.273jt5B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT6_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 3jt6A-5fjnA:undetectable3jt6B-5fjnA:undetectable | 3jt6A-5fjnA:23.273jt6B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT6_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 3jt6A-5fjnA:undetectable3jt6B-5fjnA:undetectable | 3jt6A-5fjnA:23.273jt6B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT7_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 3jt7A-5fjnA:undetectable3jt7B-5fjnA:undetectable | 3jt7A-5fjnA:23.273jt7B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT7_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 3jt7A-5fjnA:undetectable3jt7B-5fjnA:undetectable | 3jt7A-5fjnA:23.273jt7B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT9_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 3jt9A-5fjnA:undetectable3jt9B-5fjnA:undetectable | 3jt9A-5fjnA:23.273jt9B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT9_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.35A | 3jt9A-5fjnA:undetectable3jt9B-5fjnA:undetectable | 3jt9A-5fjnA:23.273jt9B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JTA_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 3jtaA-5fjnA:undetectable3jtaB-5fjnA:undetectable | 3jtaA-5fjnA:23.273jtaB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JTA_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.35A | 3jtaA-5fjnA:undetectable3jtaB-5fjnA:undetectable | 3jtaA-5fjnA:23.273jtaB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JWT_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.39A | 3jwtA-5fjnA:undetectable3jwtB-5fjnA:undetectable | 3jwtA-5fjnA:23.273jwtB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JX0_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 3jx0A-5fjnA:undetectable3jx0B-5fjnA:undetectable | 3jx0A-5fjnA:23.273jx0B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JX1_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.41A | 3jx1A-5fjnA:undetectable3jx1B-5fjnA:undetectable | 3jx1A-5fjnA:23.273jx1B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JX1_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 8 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.39A | 3jx1A-5fjnA:undetectable3jx1B-5fjnA:undetectable | 3jx1A-5fjnA:23.273jx1B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JX4_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 3jx4A-5fjnA:undetectable3jx4B-5fjnA:undetectable | 3jx4A-5fjnA:23.543jx4B-5fjnA:23.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JX5_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.27A | 3jx5A-5fjnA:undetectable3jx5B-5fjnA:undetectable | 3jx5A-5fjnA:23.543jx5B-5fjnA:23.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K9F_H_LFXH0_1 (DNA TOPOISOMERASE 4SUBUNIT ADNA TOPOISOMERASE 4SUBUNIT B) |
2euh | NADP DEPENDENT NONPHOSPHORYLATINGGLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (Streptococcusmutans) | 4 / 6 | ARG A 437SER A 162GLY A 230GLU A 236 | NAP A 476 (-4.5A)NoneNAP A 476 (-3.1A)None | 1.11A | 3k9fA-2euhA:undetectable3k9fB-2euhA:undetectable3k9fD-2euhA:2.0 | 3k9fA-2euhA:23.483k9fB-2euhA:23.483k9fD-2euhA:20.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LD6_A_KKKA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
2pbj | PROSTAGLANDIN ESYNTHASE 2 (Macacafascicularis) | 5 / 12 | TYR A 107PHE A 261PHE A 270GLY A 282ILE A 140 | HEM A 476 (-4.0A)NoneNoneNoneNone | 1.20A | 3ld6A-2pbjA:undetectable | 3ld6A-2pbjA:21.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LDW_A_ZOLA397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.05A | 3ldwA-4jzxA:44.6 | 3ldwA-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LDW_A_ZOLA397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.86A | 3ldwA-4jzxA:44.6 | 3ldwA-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LDW_A_ZOLA397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 9 | ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.62A | 3ldwA-4jzxA:44.6 | 3ldwA-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LDW_B_ZOLB397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.12A | 3ldwB-4jzxA:44.0 | 3ldwB-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LDW_B_ZOLB397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.73A | 3ldwB-4jzxA:44.0 | 3ldwB-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LDW_B_ZOLB397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 9 | ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.51A | 3ldwB-4jzxA:44.0 | 3ldwB-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LDW_C_ZOLC397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.83A | 3ldwC-4jzxA:44.5 | 3ldwC-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LDW_C_ZOLC397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 9 | ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.60A | 3ldwC-4jzxA:44.5 | 3ldwC-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LDW_D_ZOLD397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.14A | 3ldwD-4jzxA:43.7 | 3ldwD-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LDW_D_ZOLD397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.72A | 3ldwD-4jzxA:43.7 | 3ldwD-4jzxA:33.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LDW_D_ZOLD397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 9 | ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.50A | 3ldwD-4jzxA:43.7 | 3ldwD-4jzxA:33.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N2R_B_H4BB760_1 (NITRIC OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 3n2rA-5fjnA:undetectable3n2rB-5fjnA:undetectable | 3n2rA-5fjnA:23.273n2rB-5fjnA:23.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N45_F_ZOLF354_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 11 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.12A | 3n45F-4jzxA:45.1 | 3n45F-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N45_F_ZOLF354_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 11 | LEU A 95ARG A 107THR A 212TYR A 211LYS A 264 | None476 A 402 (-2.9A)IPE A 401 ( 4.6A)None476 A 402 (-2.9A) | 1.48A | 3n45F-4jzxA:45.1 | 3n45F-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N45_F_ZOLF354_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.64A | 3n45F-4jzxA:45.1 | 3n45F-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N45_F_ZOLF354_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 10 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208TYR A 211GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)NoneIPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.42A | 3n45F-4jzxA:45.1 | 3n45F-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N46_F_ZOLF354_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.14A | 3n46F-4jzxA:44.8 | 3n46F-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N46_F_ZOLF354_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.64A | 3n46F-4jzxA:44.8 | 3n46F-4jzxA:38.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N46_F_ZOLF354_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.40A | 3n46F-4jzxA:44.8 | 3n46F-4jzxA:38.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N5V_B_H4BB760_1 (NITRIC OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.35A | 3n5vA-5fjnA:undetectable3n5vB-5fjnA:undetectable | 3n5vA-5fjnA:23.273n5vB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N5Y_B_H4BB760_1 (NITRIC OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 3n5yA-5fjnA:undetectable3n5yB-5fjnA:undetectable | 3n5yA-5fjnA:23.273n5yB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N5Z_B_H4BB760_1 (NITRIC OXIDESYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 3n5zA-5fjnA:undetectable3n5zB-5fjnA:undetectable | 3n5zA-5fjnA:23.273n5zB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLM_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.39A | 3nlmA-5fjnA:undetectable3nlmB-5fjnA:undetectable | 3nlmA-5fjnA:23.273nlmB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLN_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.35A | 3nlnA-5fjnA:undetectable3nlnB-5fjnA:undetectable | 3nlnA-5fjnA:23.273nlnB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLO_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.36A | 3nloA-5fjnA:undetectable3nloB-5fjnA:undetectable | 3nloA-5fjnA:23.273nloB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLO_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.34A | 3nloA-5fjnA:undetectable3nloB-5fjnA:undetectable | 3nloA-5fjnA:23.273nloB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLP_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.28A | 3nlpA-5fjnA:undetectable3nlpB-5fjnA:undetectable | 3nlpA-5fjnA:23.543nlpB-5fjnA:23.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLV_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.35A | 3nlvA-5fjnA:undetectable3nlvB-5fjnA:undetectable | 3nlvA-5fjnA:23.273nlvB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLW_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 3nlwA-5fjnA:undetectable3nlwB-5fjnA:undetectable | 3nlwA-5fjnA:23.273nlwB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLZ_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.38A | 3nlzA-5fjnA:undetectable3nlzB-5fjnA:undetectable | 3nlzA-5fjnA:23.273nlzB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NNZ_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 3nnzA-5fjnA:undetectable3nnzB-5fjnA:undetectable | 3nnzA-5fjnA:23.273nnzB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PNE_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.39A | 3pneA-5fjnA:undetectable3pneB-5fjnA:undetectable | 3pneA-5fjnA:23.273pneB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PNF_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.38A | 3pnfA-5fjnA:undetectable3pnfB-5fjnA:undetectable | 3pnfA-5fjnA:23.273pnfB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PNG_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.42A | 3pngA-5fjnA:undetectable3pngB-5fjnA:undetectable | 3pngA-5fjnA:23.273pngB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PNG_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.41A | 3pngA-5fjnA:undetectable3pngB-5fjnA:undetectable | 3pngA-5fjnA:23.273pngB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q99_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.28A | 3q99A-5fjnA:undetectable3q99B-5fjnA:undetectable | 3q99A-5fjnA:23.273q99B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q9A_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.29A | 3q9aA-5fjnA:undetectable3q9aB-5fjnA:undetectable | 3q9aA-5fjnA:23.273q9aB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q9A_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 3q9aA-5fjnA:undetectable3q9aB-5fjnA:undetectable | 3q9aA-5fjnA:23.273q9aB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQJ_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.40A | 3rqjA-5fjnA:undetectable3rqjB-5fjnA:undetectable | 3rqjA-5fjnA:23.273rqjB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQJ_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.36A | 3rqjA-5fjnA:undetectable3rqjB-5fjnA:undetectable | 3rqjA-5fjnA:23.273rqjB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQK_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.41A | 3rqkA-5fjnA:undetectable3rqkB-5fjnA:undetectable | 3rqkA-5fjnA:23.273rqkB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQM_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.39A | 3rqmA-5fjnA:undetectable3rqmB-5fjnA:undetectable | 3rqmA-5fjnA:23.273rqmB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQN_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.43A | 3rqnA-5fjnA:undetectable3rqnB-5fjnA:undetectable | 3rqnA-5fjnA:23.273rqnB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S8P_B_SAMB500_1 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1) |
3nxl | GLUCARATEDEHYDRATASE (Burkholderialata) | 3 / 3 | HIS A 359SER A 367ASN A 362 | MG A 476 ( 4.5A)NoneCO3 A 477 ( 4.8A) | 0.90A | 3s8pB-3nxlA:0.0 | 3s8pB-3nxlA:19.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SVP_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.38A | 3svpA-5fjnA:undetectable3svpB-5fjnA:undetectable | 3svpA-5fjnA:23.273svpB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SVP_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.37A | 3svpA-5fjnA:undetectable3svpB-5fjnA:undetectable | 3svpA-5fjnA:23.273svpB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SVQ_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.33A | 3svqA-5fjnA:undetectable3svqB-5fjnA:undetectable | 3svqA-5fjnA:23.273svqB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SVQ_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.35A | 3svqA-5fjnA:undetectable3svqB-5fjnA:undetectable | 3svqA-5fjnA:23.273svqB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TYL_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 3tylA-5fjnA:undetectable3tylB-5fjnA:undetectable | 3tylA-5fjnA:23.273tylB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TYM_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 3tymA-5fjnA:undetectable3tymB-5fjnA:undetectable | 3tymA-5fjnA:23.273tymB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TYN_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 3tynA-5fjnA:undetectable3tynB-5fjnA:undetectable | 3tynA-5fjnA:23.273tynB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TYO_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 3tyoA-5fjnA:undetectable3tyoB-5fjnA:undetectable | 3tyoA-5fjnA:23.273tyoB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UFO_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.34A | 3ufoA-5fjnA:undetectable3ufoB-5fjnA:undetectable | 3ufoA-5fjnA:23.273ufoB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UFQ_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.28A | 3ufqA-5fjnA:undetectable3ufqB-5fjnA:undetectable | 3ufqA-5fjnA:23.273ufqB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UFT_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.35A | 3uftA-5fjnA:undetectable3uftB-5fjnA:undetectable | 3uftA-5fjnA:23.273uftB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UFT_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.40A | 3uftA-5fjnA:undetectable3uftB-5fjnA:undetectable | 3uftA-5fjnA:23.273uftB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UFU_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.37A | 3ufuA-5fjnA:undetectable3ufuB-5fjnA:undetectable | 3ufuA-5fjnA:23.273ufuB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UFV_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 3ufvA-5fjnA:undetectable3ufvB-5fjnA:undetectable | 3ufvA-5fjnA:23.273ufvB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UFW_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.37A | 3ufwA-5fjnA:undetectable3ufwB-5fjnA:undetectable | 3ufwA-5fjnA:23.273ufwB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UGR_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
4a5p | PROTEIN MXIA (Shigellaflexneri) | 5 / 12 | TYR A 483LEU A 486SER A 477PHE A 428PHE A 367 | NoneNoneMLY A 476 ( 4.9A)NoneNone | 1.49A | 3ugrA-4a5pA:undetectable | 3ugrA-4a5pA:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V4T_E_ACTE502_0 (UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 3 / 3 | LYS A 264ARG A 51LEU A 95 | 476 A 402 (-2.9A)IPE A 401 (-2.8A)None | 1.42A | 3v4tE-4jzxA:undetectable | 3v4tE-4jzxA:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZOS_A_0LIA1000_2 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
3pm9 | PUTATIVEOXIDOREDUCTASE (Rhodopseudomonaspalustris) | 5 / 9 | ILE A 468MET A 469LEU A 77ILE A 99ILE A 215 | NoneNoneNoneNoneFAD A 476 (-4.6A) | 1.07A | 3zosA-3pm9A:undetectable | 3zosA-3pm9A:22.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C39_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 4c39A-5fjnA:undetectable4c39B-5fjnA:undetectable | 4c39A-5fjnA:23.274c39B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CAN_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.35A | 4canA-5fjnA:undetectable4canB-5fjnA:undetectable | 4canA-5fjnA:23.274canB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CAO_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 4caoA-5fjnA:undetectable4caoB-5fjnA:undetectable | 4caoA-5fjnA:23.274caoB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CAP_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 8 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 4capA-5fjnA:undetectable4capB-5fjnA:undetectable | 4capA-5fjnA:23.274capB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CAQ_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 4caqA-5fjnA:undetectable4caqB-5fjnA:undetectable | 4caqA-5fjnA:23.274caqB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CAQ_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 4caqA-5fjnA:undetectable4caqB-5fjnA:undetectable | 4caqA-5fjnA:23.274caqB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTP_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 4ctpA-5fjnA:undetectable4ctpB-5fjnA:undetectable | 4ctpA-5fjnA:23.274ctpB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTR_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.34A | 4ctrA-5fjnA:undetectable4ctrB-5fjnA:undetectable | 4ctrA-5fjnA:23.274ctrB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTT_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 4cttA-5fjnA:undetectable4cttB-5fjnA:undetectable | 4cttA-5fjnA:23.274cttB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTU_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 4ctuA-5fjnA:undetectable4ctuB-5fjnA:undetectable | 4ctuA-5fjnA:23.274ctuB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTW_B_H4BB1720_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.35A | 4ctwA-5fjnA:undetectable4ctwB-5fjnA:undetectable | 4ctwA-5fjnA:23.274ctwB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTX_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.39A | 4ctxA-5fjnA:undetectable4ctxB-5fjnA:undetectable | 4ctxA-5fjnA:23.274ctxB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTX_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.37A | 4ctxA-5fjnA:undetectable4ctxB-5fjnA:undetectable | 4ctxA-5fjnA:23.274ctxB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CX4_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 4cx4A-5fjnA:undetectable4cx4B-5fjnA:undetectable | 4cx4A-5fjnA:23.544cx4B-5fjnA:23.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CX5_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.37A | 4cx5A-5fjnA:undetectable4cx5B-5fjnA:undetectable | 4cx5A-5fjnA:23.274cx5B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CX6_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.33A | 4cx6A-5fjnA:undetectable4cx6B-5fjnA:undetectable | 4cx6A-5fjnA:23.274cx6B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CX6_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.34A | 4cx6A-5fjnA:undetectable4cx6B-5fjnA:undetectable | 4cx6A-5fjnA:23.274cx6B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D1N_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 4d1nA-5fjnA:undetectable4d1nB-5fjnA:undetectable | 4d1nA-5fjnA:23.094d1nB-5fjnA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D1N_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 4d1nA-5fjnA:undetectable4d1nB-5fjnA:undetectable | 4d1nA-5fjnA:23.094d1nB-5fjnA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D1N_C_H4BC760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 4d1nC-5fjnA:undetectable4d1nD-5fjnA:undetectable | 4d1nC-5fjnA:23.094d1nD-5fjnA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D2Y_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 4d2yA-5fjnA:undetectable4d2yB-5fjnA:undetectable | 4d2yA-5fjnA:23.274d2yB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D2Y_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 4d2yA-5fjnA:undetectable4d2yB-5fjnA:undetectable | 4d2yA-5fjnA:23.274d2yB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D2Z_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.34A | 4d2zA-5fjnA:undetectable4d2zB-5fjnA:undetectable | 4d2zA-5fjnA:23.274d2zB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D30_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 4d30A-5fjnA:undetectable4d30B-5fjnA:undetectable | 4d30A-5fjnA:23.274d30B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D30_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 4d30A-5fjnA:undetectable4d30B-5fjnA:undetectable | 4d30A-5fjnA:23.274d30B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D31_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 4d31A-5fjnA:undetectable4d31B-5fjnA:undetectable | 4d31A-5fjnA:23.274d31B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D32_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 4d32A-5fjnA:undetectable4d32B-5fjnA:undetectable | 4d32A-5fjnA:23.274d32B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D32_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 8 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 4d32A-5fjnA:undetectable4d32B-5fjnA:undetectable | 4d32A-5fjnA:23.274d32B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D3B_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 4d3bA-5fjnA:undetectable4d3bB-5fjnA:undetectable | 4d3bA-5fjnA:23.274d3bB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D3B_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 4d3bA-5fjnA:undetectable4d3bB-5fjnA:undetectable | 4d3bA-5fjnA:23.274d3bB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D7O_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 4d7oA-5fjnA:undetectable4d7oB-5fjnA:undetectable | 4d7oA-5fjnA:23.274d7oB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D7O_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 4d7oA-5fjnA:undetectable4d7oB-5fjnA:undetectable | 4d7oA-5fjnA:23.274d7oB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EAT_B_BEZB1000_0 (BENZOATE-COENZYME ALIGASE) |
2euh | NADP DEPENDENT NONPHOSPHORYLATINGGLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (Streptococcusmutans) | 5 / 9 | ALA A 452GLY A 230ILE A 234GLY A 235ILE A 238 | NoneNAP A 476 (-3.1A)NAP A 476 (-3.8A)NoneNone | 1.12A | 4eatB-2euhA:2.6 | 4eatB-2euhA:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EUX_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.36A | 4euxA-5fjnA:undetectable4euxB-5fjnA:undetectable | 4euxA-5fjnA:23.274euxB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EUX_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 4euxA-5fjnA:undetectable4euxB-5fjnA:undetectable | 4euxA-5fjnA:23.274euxB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FGL_C_CLQC303_0 (RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE[QUINONE]) |
3pm9 | PUTATIVEOXIDOREDUCTASE (Rhodopseudomonaspalustris) | 4 / 5 | GLY A 88GLY A 89ASN A 470GLU A 42 | NoneFAD A 476 (-3.7A)FAD A 476 (-4.0A)None | 1.16A | 4fglC-3pm9A:undetectable | 4fglC-3pm9A:19.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FVY_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 4fvyA-5fjnA:undetectable4fvyB-5fjnA:undetectable | 4fvyA-5fjnA:23.274fvyB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FVY_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 4fvyA-5fjnA:undetectable4fvyB-5fjnA:undetectable | 4fvyA-5fjnA:23.274fvyB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FVZ_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.25A | 4fvzA-5fjnA:undetectable4fvzB-5fjnA:undetectable | 4fvzA-5fjnA:23.274fvzB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FVZ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 4fvzA-5fjnA:undetectable4fvzB-5fjnA:undetectable | 4fvzA-5fjnA:23.274fvzB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FW0_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 4fw0A-5fjnA:undetectable4fw0B-5fjnA:undetectable | 4fw0A-5fjnA:23.274fw0B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FW0_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 4fw0A-5fjnA:undetectable4fw0B-5fjnA:undetectable | 4fw0A-5fjnA:23.274fw0B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4G2Z_A_ID8A711_1 (LACTOTRANSFERRIN) |
2pbj | PROSTAGLANDIN ESYNTHASE 2 (Macacafascicularis) | 3 / 3 | PRO A 134TYR A 107GLY A 268 | HEM A 476 (-4.1A)HEM A 476 (-4.0A)None | 0.71A | 4g2zA-2pbjA:undetectable | 4g2zA-2pbjA:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HVC_B_HFGB1602_0 (BIFUNCTIONALGLUTAMATE/PROLINE--TRNA LIGASE) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 5 / 12 | LEU A 176GLU A 245GLU A 45SER A 43GLY A 328 | NoneNoneIF6 A1476 (-2.9A)NoneNone | 1.20A | 4hvcB-5g0qA:undetectable | 4hvcB-5g0qA:20.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HYT_A_OBNA1104_2 (SODIUM/POTASSIUM-TRANSPORTING ATPASESUBUNIT ALPHA-1) |
4b2q | ATP SYNTHASE SUBUNITBETA, MITOCHONDRIAL (Saccharomycescerevisiae) | 4 / 5 | PRO D 350ASP D 349ILE D 344VAL D 161 | NoneNoneNoneADP D1476 (-4.4A) | 1.14A | 4hytA-4b2qD:undetectable | 4hytA-4b2qD:19.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IMT_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 4imtA-5fjnA:undetectable4imtB-5fjnA:undetectable | 4imtA-5fjnA:23.274imtB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IMT_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 4imtA-5fjnA:undetectable4imtB-5fjnA:undetectable | 4imtA-5fjnA:23.274imtB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IMW_A_H4BA805_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 4imwA-5fjnA:undetectable4imwB-5fjnA:undetectable | 4imwA-5fjnA:23.274imwB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JSF_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 4jsfA-5fjnA:undetectable4jsfB-5fjnA:undetectable | 4jsfA-5fjnA:23.274jsfB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JSG_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.28A | 4jsgA-5fjnA:undetectable4jsgB-5fjnA:undetectable | 4jsgA-5fjnA:23.274jsgB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JSH_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.36A | 4jshA-5fjnA:undetectable4jshB-5fjnA:undetectable | 4jshA-5fjnA:23.274jshB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JSI_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 4jsiA-5fjnA:undetectable4jsiB-5fjnA:undetectable | 4jsiA-5fjnA:23.274jsiB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JSJ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 4jsjA-5fjnA:undetectable4jsjB-5fjnA:undetectable | 4jsjA-5fjnA:23.274jsjB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K5D_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 4k5dA-5fjnA:undetectable4k5dB-5fjnA:undetectable | 4k5dA-5fjnA:23.274k5dB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K5D_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 4k5dA-5fjnA:undetectable4k5dB-5fjnA:undetectable | 4k5dA-5fjnA:23.274k5dB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K5E_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 4k5eA-5fjnA:undetectable4k5eB-5fjnA:undetectable | 4k5eA-5fjnA:23.274k5eB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K5F_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.33A | 4k5fA-5fjnA:undetectable4k5fB-5fjnA:undetectable | 4k5fA-5fjnA:23.274k5fB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K5F_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 4k5fA-5fjnA:undetectable4k5fB-5fjnA:undetectable | 4k5fA-5fjnA:23.274k5fB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K5G_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.33A | 4k5gA-5fjnA:undetectable4k5gB-5fjnA:undetectable | 4k5gA-5fjnA:23.274k5gB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCH_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.33A | 4kchA-5fjnA:undetectable4kchB-5fjnA:undetectable | 4kchA-5fjnA:23.274kchB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCH_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 4kchA-5fjnA:undetectable4kchB-5fjnA:undetectable | 4kchA-5fjnA:23.274kchB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCI_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 4kciA-5fjnA:undetectable4kciB-5fjnA:undetectable | 4kciA-5fjnA:23.274kciB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCI_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 4kciA-5fjnA:undetectable4kciB-5fjnA:undetectable | 4kciA-5fjnA:23.274kciB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCJ_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 4kcjA-5fjnA:undetectable4kcjB-5fjnA:undetectable | 4kcjA-5fjnA:23.274kcjB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCJ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 4kcjA-5fjnA:undetectable4kcjB-5fjnA:undetectable | 4kcjA-5fjnA:23.274kcjB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCL_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 4kclA-5fjnA:undetectable4kclB-5fjnA:undetectable | 4kclA-5fjnA:23.274kclB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCM_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 4kcmA-5fjnA:undetectable4kcmB-5fjnA:undetectable | 4kcmA-5fjnA:23.274kcmB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCN_A_MTLA804_0 (NITRIC OXIDESYNTHASE, BRAIN) |
2euh | NADP DEPENDENT NONPHOSPHORYLATINGGLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (Streptococcusmutans) | 4 / 6 | GLU A 100ARG A 103ASP A 440ARG A 437 | NoneNoneNoneNAP A 476 (-4.5A) | 1.16A | 4kcnA-2euhA:undetectable | 4kcnA-2euhA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCN_B_MTLB805_0 (NITRIC OXIDESYNTHASE, BRAIN) |
2euh | NADP DEPENDENT NONPHOSPHORYLATINGGLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (Streptococcusmutans) | 4 / 6 | GLU A 100ARG A 103ASP A 440ARG A 437 | NoneNoneNoneNAP A 476 (-4.5A) | 1.11A | 4kcnB-2euhA:undetectable | 4kcnB-2euhA:22.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KFA_A_ZOLA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.11A | 4kfaA-4jzxA:43.9 | 4kfaA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KFA_A_ZOLA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 9 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.66A | 4kfaA-4jzxA:43.9 | 4kfaA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KPD_A_RISA405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.12A | 4kpdA-4jzxA:45.3 | 4kpdA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KPD_A_RISA405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.63A | 4kpdA-4jzxA:45.3 | 4kpdA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KPD_A_RISA405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.37A | 4kpdA-4jzxA:45.3 | 4kpdA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KPJ_A_210A901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.12A | 4kpjA-4jzxA:43.9 | 4kpjA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KPJ_A_210A901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 9 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.43A | 4kpjA-4jzxA:43.9 | 4kpjA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KQ5_A_ZOLA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.11A | 4kq5A-4jzxA:44.3 | 4kq5A-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KQ5_A_ZOLA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.68A | 4kq5A-4jzxA:44.3 | 4kq5A-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KQ5_A_ZOLA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.47A | 4kq5A-4jzxA:44.3 | 4kq5A-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KQS_A_RISA405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.12A | 4kqsA-4jzxA:45.0 | 4kqsA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KQS_A_RISA405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.62A | 4kqsA-4jzxA:45.0 | 4kqsA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KQS_A_RISA405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.40A | 4kqsA-4jzxA:45.0 | 4kqsA-4jzxA:36.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LXZ_A_SHHA407_1 (HISTONE DEACETYLASE2) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 5 / 12 | ASP A 433HIS A 347HIS A 435GLY A 434ASP A 56 | MG A1480 (-2.4A) ZN A1476 ( 3.1A) ZN A1475 ( 3.2A)None ZN A1476 (-2.2A) | 1.01A | 4lxzA-2x98A:3.0 | 4lxzA-2x98A:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LXZ_C_SHHC406_1 (HISTONE DEACETYLASE2) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 5 / 12 | ASP A 433HIS A 347HIS A 435GLY A 434ASP A 56 | MG A1480 (-2.4A) ZN A1476 ( 3.1A) ZN A1475 ( 3.2A)None ZN A1476 (-2.2A) | 1.03A | 4lxzC-2x98A:3.2 | 4lxzC-2x98A:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LXZ_C_SHHC406_1 (HISTONE DEACETYLASE2) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 5 / 12 | HIS A 435HIS A 308GLY A 307ASP A 56GLY A 57 | ZN A1475 ( 3.2A) ZN A1475 ( 3.2A)None ZN A1476 (-2.2A)None | 1.21A | 4lxzC-2x98A:3.2 | 4lxzC-2x98A:20.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9U_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.11A | 4n9uA-4jzxA:44.1 | 4n9uA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9U_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.63A | 4n9uA-4jzxA:44.1 | 4n9uA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9U_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107THR A 163THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-4.8A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.46A | 4n9uA-4jzxA:44.1 | 4n9uA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9U_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107THR A 208 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 ( 3.4A) | 1.34A | 4n9uA-4jzxA:44.1 | 4n9uA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NG6_A_RISA405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 12 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.11A | 4ng6A-4jzxA:45.3 | 4ng6A-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NG6_A_RISA405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 11 / 12 | LEU A 95ASP A 98ASP A 102ARG A 107THR A 163GLN A 167THR A 208TYR A 211GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-4.8A)476 A 402 (-3.5A)IPE A 401 ( 3.4A)NoneIPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.41A | 4ng6A-4jzxA:45.3 | 4ng6A-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKE_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.74A | 4nkeA-4jzxA:44.2 | 4nkeA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKE_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.60A | 4nkeA-4jzxA:44.2 | 4nkeA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKE_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | LEU A 95ASP A 98ASP A 102GLN A 167THR A 163 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-3.5A)476 A 402 (-4.8A) | 1.49A | 4nkeA-4jzxA:44.2 | 4nkeA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKF_A_210A404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.09A | 4nkfA-4jzxA:44.2 | 4nkfA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKF_A_210A404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 9 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.47A | 4nkfA-4jzxA:44.2 | 4nkfA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NUA_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.31A | 4nuaA-4jzxA:44.3 | 4nuaA-4jzxA:36.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NUA_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.79A | 4nuaA-4jzxA:44.3 | 4nuaA-4jzxA:36.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NUA_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.66A | 4nuaA-4jzxA:44.3 | 4nuaA-4jzxA:36.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OGU_A_210A405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.09A | 4oguA-4jzxA:44.1 | 4oguA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OGU_A_210A405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 9 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.40A | 4oguA-4jzxA:44.1 | 4oguA-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P0V_A_ZOLA401_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.14A | 4p0vA-4jzxA:45.6 | 4p0vA-4jzxA:38.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P0V_A_ZOLA401_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 9 | ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.63A | 4p0vA-4jzxA:45.6 | 4p0vA-4jzxA:38.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P0V_A_ZOLA401_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 8 / 9 | ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.45A | 4p0vA-4jzxA:45.6 | 4p0vA-4jzxA:38.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P0W_A_ZOLA501_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 11 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.10A | 4p0wA-4jzxA:45.6 | 4p0wA-4jzxA:38.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P0W_A_ZOLA501_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 11 | LEU A 95ARG A 107THR A 212TYR A 211LYS A 264 | None476 A 402 (-2.9A)IPE A 401 ( 4.6A)None476 A 402 (-2.9A) | 1.47A | 4p0wA-4jzxA:45.6 | 4p0wA-4jzxA:38.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P0W_A_ZOLA501_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.62A | 4p0wA-4jzxA:45.6 | 4p0wA-4jzxA:38.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P0W_A_ZOLA501_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 10 / 11 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208TYR A 211GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)NoneIPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.43A | 4p0wA-4jzxA:45.6 | 4p0wA-4jzxA:38.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PAE_A_NIZA804_1 (CATALASE-PEROXIDASE) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 4 / 6 | PHE A 122ASP A 56HIS A 347THR A 113 | None ZN A1476 (-2.2A) ZN A1476 ( 3.1A)None | 1.28A | 4paeA-2x98A:undetectable | 4paeA-2x98A:22.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q15_B_HFGB803_0 (PROLINE--TRNA LIGASE) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 5 / 12 | LEU A 176GLU A 245GLU A 45SER A 43GLY A 328 | NoneNoneIF6 A1476 (-2.9A)NoneNone | 1.24A | 4q15B-5g0qA:undetectable | 4q15B-5g0qA:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q15_B_HFGB803_0 (PROLINE--TRNA LIGASE) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 5 / 12 | LEU A 176GLU A 245GLU A 45SER A 43GLY A 329 | NoneNoneIF6 A1476 (-2.9A)NoneNone | 1.36A | 4q15B-5g0qA:undetectable | 4q15B-5g0qA:20.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Q23_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.63A | 4q23A-4jzxA:44.1 | 4q23A-4jzxA:36.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Q23_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207TYR A 211GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)NoneIPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.37A | 4q23A-4jzxA:44.1 | 4q23A-4jzxA:36.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVQ_K_BO2K301_1 (PROTEASOME SUBUNITBETA TYPE-5PROTEASOME SUBUNITBETA TYPE-6) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 5 / 9 | THR A 128ALA A 118ILE A 133GLY A 131ASP A 56 | NoneNoneNoneNone ZN A1476 (-2.2A) | 1.12A | 4qvqK-2x98A:undetectable4qvqL-2x98A:undetectable | 4qvqK-2x98A:23.354qvqL-2x98A:17.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVQ_Y_BO2Y301_1 (PROTEASOME SUBUNITBETA TYPE-5PROTEASOME SUBUNITBETA TYPE-6) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 5 / 9 | THR A 128ALA A 118ILE A 133GLY A 131ASP A 56 | NoneNoneNoneNone ZN A1476 (-2.2A) | 1.12A | 4qvqY-2x98A:undetectable4qvqZ-2x98A:undetectable | 4qvqY-2x98A:23.354qvqZ-2x98A:17.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QZT_B_ACTB201_0 (RETINOL-BINDINGPROTEIN 2) |
3ubr | CYTOCHROME C-552 (Shewanellaoneidensis) | 4 / 5 | TYR A 79TYR A 235GLU A 205GLN A 256 | NoneNone CA A 476 (-2.4A) CA A 476 (-3.2A) | 1.22A | 4qztB-3ubrA:undetectable | 4qztB-3ubrA:15.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QZT_B_ACTB201_0 (RETINOL-BINDINGPROTEIN 2) |
3ubr | CYTOCHROME C-552 (Shewanellaoneidensis) | 4 / 5 | TYR A 235GLU A 205LEU A 253GLN A 256 | None CA A 476 (-2.4A)None CA A 476 (-3.2A) | 0.88A | 4qztB-3ubrA:undetectable | 4qztB-3ubrA:15.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R38_A_RBFA201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
2euh | NADP DEPENDENT NONPHOSPHORYLATINGGLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (Streptococcusmutans) | 5 / 12 | GLN A 455ALA A 149ILE A 150LEU A 249GLY A 235 | NoneNoneNAP A 476 (-4.5A)NoneNone | 1.23A | 4r38A-2euhA:undetectable | 4r38A-2euhA:15.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RXD_A_RISA1404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.67A | 4rxdA-4jzxA:54.0 | 4rxdA-4jzxA:58.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RXD_A_RISA1404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.45A | 4rxdA-4jzxA:54.0 | 4rxdA-4jzxA:58.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RXD_B_RISB1504_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.66A | 4rxdB-4jzxA:54.4 | 4rxdB-4jzxA:58.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RXD_B_RISB1504_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.45A | 4rxdB-4jzxA:54.4 | 4rxdB-4jzxA:58.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RXD_C_RISC1600_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.66A | 4rxdC-4jzxA:54.4 | 4rxdC-4jzxA:58.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RXD_C_RISC1600_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 9 / 10 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.44A | 4rxdC-4jzxA:54.4 | 4rxdC-4jzxA:58.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UCH_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 4uchA-5fjnA:undetectable4uchB-5fjnA:undetectable | 4uchA-5fjnA:23.404uchB-5fjnA:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UCH_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 8 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.34A | 4uchA-5fjnA:undetectable4uchB-5fjnA:undetectable | 4uchA-5fjnA:23.404uchB-5fjnA:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UGZ_A_H4BA760_1 (NEURONAL NITRICOXIDE SYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 4ugzA-5fjnA:undetectable4ugzB-5fjnA:undetectable | 4ugzA-5fjnA:23.274ugzB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH1_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 4uh1A-5fjnA:undetectable4uh1B-5fjnA:undetectable | 4uh1A-5fjnA:23.274uh1B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH1_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 4uh1A-5fjnA:undetectable4uh1B-5fjnA:undetectable | 4uh1A-5fjnA:23.274uh1B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH3_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.33A | 4uh3A-5fjnA:undetectable4uh3B-5fjnA:undetectable | 4uh3A-5fjnA:23.274uh3B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH3_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 4uh3A-5fjnA:undetectable4uh3B-5fjnA:undetectable | 4uh3A-5fjnA:23.274uh3B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH4_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 4uh4A-5fjnA:undetectable4uh4B-5fjnA:undetectable | 4uh4A-5fjnA:23.274uh4B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH4_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 4uh4A-5fjnA:undetectable4uh4B-5fjnA:undetectable | 4uh4A-5fjnA:23.274uh4B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH5_A_H4BA760_1 (NEURONAL NITRICOXIDE SYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 4uh5A-5fjnA:undetectable4uh5B-5fjnA:undetectable | 4uh5A-5fjnA:23.664uh5B-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH6_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.30A | 4uh6A-5fjnA:undetectable4uh6B-5fjnA:undetectable | 4uh6A-5fjnA:23.664uh6B-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH6_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 4uh6A-5fjnA:undetectable4uh6B-5fjnA:undetectable | 4uh6A-5fjnA:23.664uh6B-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UMJ_A_BFQA1297_1 (GERANYLTRANSTRANSFERASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 6 / 8 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A) | 0.50A | 4umjA-4jzxA:24.1 | 4umjA-4jzxA:27.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UMJ_B_BFQB1294_1 (GERANYLTRANSTRANSFERASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207THR A 208 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 ( 3.4A) | 0.53A | 4umjB-4jzxA:24.2 | 4umjB-4jzxA:27.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UMJ_B_BFQB1294_1 (GERANYLTRANSTRANSFERASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | LEU A 95ASP A 98ASP A 102ARG A 107THR A 163 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-4.8A) | 1.14A | 4umjB-4jzxA:24.2 | 4umjB-4jzxA:27.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UPN_B_H4BB760_1 (NEURONAL NITRICOXIDE SYNTHASE) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 4upnA-5fjnA:undetectable4upnB-5fjnA:undetectable | 4upnA-5fjnA:23.274upnB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UPO_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 4upoA-5fjnA:undetectable4upoB-5fjnA:undetectable | 4upoA-5fjnA:23.274upoB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UPP_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 4uppA-5fjnA:undetectable4uppB-5fjnA:undetectable | 4uppA-5fjnA:23.274uppB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3U_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 4v3uA-5fjnA:undetectable4v3uB-5fjnA:undetectable | 4v3uA-5fjnA:23.094v3uB-5fjnA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3U_C_H4BC760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 4v3uC-5fjnA:undetectable4v3uD-5fjnA:undetectable | 4v3uC-5fjnA:23.094v3uD-5fjnA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3U_D_H4BD760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.34A | 4v3uC-5fjnA:undetectable4v3uD-5fjnA:undetectable | 4v3uC-5fjnA:23.094v3uD-5fjnA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3X_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 4v3xA-5fjnA:undetectable4v3xB-5fjnA:undetectable | 4v3xA-5fjnA:23.274v3xB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3X_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 4v3xA-5fjnA:undetectable4v3xB-5fjnA:undetectable | 4v3xA-5fjnA:23.274v3xB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3Y_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 8 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.34A | 4v3yA-5fjnA:undetectable4v3yB-5fjnA:undetectable | 4v3yA-5fjnA:23.274v3yB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3Z_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 4v3zA-5fjnA:undetectable4v3zB-5fjnA:undetectable | 4v3zA-5fjnA:23.274v3zB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3Z_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 4v3zA-5fjnA:undetectable4v3zB-5fjnA:undetectable | 4v3zA-5fjnA:23.274v3zB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_A_HFGA802_0 (PROLINE--TRNA LIGASE) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 5 / 12 | LEU A 176GLU A 245GLU A 45SER A 43GLY A 328 | NoneNoneIF6 A1476 (-2.9A)NoneNone | 1.24A | 4ydqA-5g0qA:undetectable | 4ydqA-5g0qA:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_A_HFGA802_0 (PROLINE--TRNA LIGASE) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 5 / 12 | LEU A 176GLU A 245GLU A 45SER A 43GLY A 329 | NoneNoneIF6 A1476 (-2.9A)NoneNone | 1.37A | 4ydqA-5g0qA:undetectable | 4ydqA-5g0qA:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZJO_D_ERYD1101_0 (MULTIDRUG EFFLUXPUMP SUBUNIT ACRB) |
3pm9 | PUTATIVEOXIDOREDUCTASE (Rhodopseudomonaspalustris) | 5 / 11 | SER A 156THR A 157GLU A 42THR A 150GLY A 82 | FAD A 476 (-2.8A)FAD A 476 (-3.2A)NoneFAD A 476 (-3.1A)FAD A 476 (-3.3A) | 1.40A | 4zjoD-3pm9A:6.0 | 4zjoD-3pm9A:18.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AD5_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.30A | 5ad5A-5fjnA:undetectable5ad5B-5fjnA:undetectable | 5ad5A-5fjnA:23.275ad5B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AD5_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 5ad5A-5fjnA:undetectable5ad5B-5fjnA:undetectable | 5ad5A-5fjnA:23.275ad5B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AD6_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 5ad6A-5fjnA:undetectable5ad6B-5fjnA:undetectable | 5ad6A-5fjnA:23.275ad6B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AD7_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 5ad7A-5fjnA:undetectable5ad7B-5fjnA:undetectable | 5ad7A-5fjnA:23.275ad7B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AD8_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 5ad8A-5fjnA:undetectable5ad8B-5fjnA:undetectable | 5ad8A-5fjnA:23.275ad8B-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADB_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.26A | 5adbA-5fjnA:undetectable5adbB-5fjnA:undetectable | 5adbA-5fjnA:23.275adbB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADC_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 5adcA-5fjnA:undetectable5adcB-5fjnA:undetectable | 5adcA-5fjnA:23.275adcB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AGK_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.27A | 5agkA-5fjnA:undetectable5agkB-5fjnA:undetectable | 5agkA-5fjnA:23.275agkB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AGM_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.35A | 5agmA-5fjnA:undetectable5agmB-5fjnA:undetectable | 5agmA-5fjnA:23.275agmB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AGN_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 5agnA-5fjnA:undetectable5agnB-5fjnA:undetectable | 5agnA-5fjnA:23.275agnB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AGN_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 5agnA-5fjnA:undetectable5agnB-5fjnA:undetectable | 5agnA-5fjnA:23.275agnB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AGP_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.27A | 5agpA-5fjnA:undetectable5agpB-5fjnA:undetectable | 5agpA-5fjnA:23.275agpB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AGP_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 5agpA-5fjnA:undetectable5agpB-5fjnA:undetectable | 5agpA-5fjnA:23.275agpB-5fjnA:23.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CG5_A_RISA400_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 12 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.18A | 5cg5A-4jzxA:44.4 | 5cg5A-4jzxA:38.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CG5_A_RISA400_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 10 / 12 | LEU A 95ASP A 98ASP A 102ARG A 107THR A 163GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-4.8A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.66A | 5cg5A-4jzxA:44.4 | 5cg5A-4jzxA:38.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CG5_A_RISA400_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 11 / 12 | LEU A 95ASP A 98ASP A 102ARG A 107THR A 163LYS A 207THR A 208TYR A 211GLN A 247ASP A 250LYS A 264 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-4.8A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)NoneIPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.43A | 5cg5A-4jzxA:44.4 | 5cg5A-4jzxA:38.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CG6_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 12 | ASP A 98ARG A 107GLN A 247ASP A 250LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 1.12A | 5cg6A-4jzxA:45.2 | 5cg6A-4jzxA:38.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CG6_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 12 | PHE A 94LEU A 95ARG A 107THR A 212LYS A 264 | 476 A 402 (-4.3A)None476 A 402 (-2.9A)IPE A 401 ( 4.6A)476 A 402 (-2.9A) | 0.96A | 5cg6A-4jzxA:45.2 | 5cg6A-4jzxA:38.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CG6_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 11 / 12 | PHE A 94LEU A 95ASP A 98ASP A 102ARG A 107THR A 163GLN A 167LYS A 207GLN A 247ASP A 250LYS A 264 | 476 A 402 (-4.3A)None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-4.8A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.67A | 5cg6A-4jzxA:45.2 | 5cg6A-4jzxA:38.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CG6_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 11 / 12 | PHE A 94LEU A 95ASP A 98ASP A 102ARG A 107THR A 163LYS A 207THR A 208GLN A 247ASP A 250LYS A 264 | 476 A 402 (-4.3A)None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-4.8A)476 A 402 (-2.7A)IPE A 401 ( 3.4A)IPE A 401 (-3.7A) CA A 404 (-3.0A)476 A 402 (-2.9A) | 0.40A | 5cg6A-4jzxA:45.2 | 5cg6A-4jzxA:38.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_A_210A804_1 (FUSICOCCADIENESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | LEU A 95ASP A 98ASP A 102ARG A 107LYS A 207GLN A 247ASP A 250 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A) | 0.74A | 5eroA-4jzxA:26.9 | 5eroA-4jzxA:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_B_210B804_1 (FUSICOCCADIENESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 9 | ASP A 98ASP A 102ARG A 107LYS A 207GLN A 247ASP A 250ASP A 251 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)None | 0.78A | 5eroB-4jzxA:26.6 | 5eroB-4jzxA:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_B_210B804_1 (FUSICOCCADIENESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 9 | ASP A 98ASP A 102LYS A 207GLN A 247ASP A 250 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A) | 1.44A | 5eroB-4jzxA:26.6 | 5eroB-4jzxA:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_C_210C804_1 (FUSICOCCADIENESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 10 | ASP A 98ASP A 99ASP A 102ARG A 107LYS A 207GLN A 247ASP A 250 | CA A 403 (-2.5A)None CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A) | 0.62A | 5eroC-4jzxA:26.7 | 5eroC-4jzxA:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_C_210C804_1 (FUSICOCCADIENESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 98ASP A 102LYS A 207GLN A 247ASP A 250 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A) | 1.39A | 5eroC-4jzxA:26.7 | 5eroC-4jzxA:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_C_210C804_1 (FUSICOCCADIENESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 7 / 10 | ASP A 99ASP A 102ARG A 107LYS A 207GLN A 247ASP A 250ASP A 251 | None CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)IPE A 401 (-3.7A) CA A 404 (-3.0A)None | 0.72A | 5eroC-4jzxA:26.7 | 5eroC-4jzxA:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_C_210C804_1 (FUSICOCCADIENESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 102ARG A 107LYS A 207ASP A 251LYS A 264 | CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A)None476 A 402 (-2.9A) | 1.27A | 5eroC-4jzxA:26.7 | 5eroC-4jzxA:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_C_210C804_1 (FUSICOCCADIENESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 10 | ASP A 102ASP A 99ARG A 107ASP A 250ASP A 251 | CA A 403 (-2.5A)None476 A 402 (-2.9A) CA A 404 (-3.0A)None | 1.48A | 5eroC-4jzxA:26.7 | 5eroC-4jzxA:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5F9Z_A_HFGA702_0 (AMINOACYL-TRNASYNTHETASE) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 5 / 12 | LEU A 176GLU A 245GLU A 45SER A 43GLY A 328 | NoneNoneIF6 A1476 (-2.9A)NoneNone | 1.24A | 5f9zA-5g0qA:undetectable | 5f9zA-5g0qA:19.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5F9Z_B_HFGB703_0 (AMINOACYL-TRNASYNTHETASE) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 5 / 12 | LEU A 176GLU A 245GLU A 45SER A 43GLY A 328 | NoneNoneIF6 A1476 (-2.9A)NoneNone | 1.28A | 5f9zB-5g0qA:undetectable | 5f9zB-5g0qA:19.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVO_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 3 / 3 | ARG A 316VAL A 438TRP A 439 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 0.98A | 5fvoA-5fjnA:undetectable | 5fvoA-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVP_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.37A | 5fvpA-5fjnA:undetectable5fvpB-5fjnA:undetectable | 5fvpA-5fjnA:23.275fvpB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVP_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 5fvpA-5fjnA:undetectable5fvpB-5fjnA:undetectable | 5fvpA-5fjnA:23.275fvpB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVQ_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 5fvqA-5fjnA:undetectable5fvqB-5fjnA:undetectable | 5fvqA-5fjnA:23.275fvqB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVQ_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.26A | 5fvqA-5fjnA:undetectable5fvqB-5fjnA:undetectable | 5fvqA-5fjnA:23.275fvqB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVS_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 5fvsA-5fjnA:undetectable5fvsB-5fjnA:undetectable | 5fvsA-5fjnA:23.275fvsB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVS_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 5fvsA-5fjnA:undetectable5fvsB-5fjnA:undetectable | 5fvsA-5fjnA:23.275fvsB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVT_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 5fvtA-5fjnA:undetectable5fvtB-5fjnA:undetectable | 5fvtA-5fjnA:23.275fvtB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVT_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 5fvtA-5fjnA:undetectable5fvtB-5fjnA:undetectable | 5fvtA-5fjnA:23.275fvtB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVU_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 5fvuA-5fjnA:undetectable5fvuB-5fjnA:undetectable | 5fvuA-5fjnA:23.665fvuB-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVU_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 5fvuA-5fjnA:undetectable5fvuB-5fjnA:undetectable | 5fvuA-5fjnA:23.665fvuB-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVV_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 5fvvA-5fjnA:undetectable5fvvB-5fjnA:undetectable | 5fvvA-5fjnA:23.665fvvB-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVV_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 5fvvA-5fjnA:undetectable5fvvB-5fjnA:undetectable | 5fvvA-5fjnA:23.665fvvB-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVX_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.28A | 5fvxA-5fjnA:undetectable5fvxB-5fjnA:undetectable | 5fvxA-5fjnA:23.665fvxB-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5G0N_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.29A | 5g0nA-5fjnA:undetectable5g0nB-5fjnA:undetectable | 5g0nA-5fjnA:23.275g0nB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5G0N_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 5g0nA-5fjnA:undetectable5g0nB-5fjnA:undetectable | 5g0nA-5fjnA:23.275g0nB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5G0O_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 5g0oA-5fjnA:undetectable5g0oB-5fjnA:undetectable | 5g0oA-5fjnA:23.275g0oB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5G0P_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.28A | 5g0pA-5fjnA:undetectable5g0pB-5fjnA:undetectable | 5g0pA-5fjnA:23.545g0pB-5fjnA:23.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GQB_A_GCSA602_1 (CHITINASE) |
3nxl | GLUCARATEDEHYDRATASE (Burkholderialata) | 3 / 3 | TRP A 260GLU A 236ASP A 255 | NoneNone MG A 476 (-2.8A) | 0.50A | 5gqbA-3nxlA:5.1 | 5gqbA-3nxlA:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LF3_H_BO2H306_1 (PROTEASOME SUBUNITBETA TYPE-7PROTEASOME SUBUNITBETA TYPE-3) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 5 / 10 | THR A 128ALA A 118ALA A 132GLY A 131ASP A 56 | NoneNoneNoneNone ZN A1476 (-2.2A) | 1.14A | 5lf3H-2x98A:undetectable5lf3I-2x98A:undetectable | 5lf3H-2x98A:19.035lf3I-2x98A:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N0S_A_SAMA501_0 (PEPTIDEN-METHYLTRANSFERASE) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 5 / 12 | GLY A 345HIS A 347VAL A 303ILE A 51ALA A 52 | None ZN A1476 ( 3.1A)NoneNoneNone | 1.09A | 5n0sA-2x98A:2.4 | 5n0sA-2x98A:23.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N0W_B_SAMB501_0 (PEPTIDEN-METHYLTRANSFERASE) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 5 / 12 | GLY A 345HIS A 347VAL A 303ILE A 51ALA A 52 | None ZN A1476 ( 3.1A)NoneNoneNone | 1.09A | 5n0wB-2x98A:3.2 | 5n0wB-2x98A:23.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N0X_A_SAMA501_0 (PEPTIDEN-METHYLTRANSFERASE) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 5 / 12 | GLY A 345HIS A 347VAL A 303ILE A 51ALA A 52 | None ZN A1476 ( 3.1A)NoneNoneNone | 1.09A | 5n0xA-2x98A:3.1 | 5n0xA-2x98A:23.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NNW_D_GCSD302_1 (25 KDA PROTEINELICITOR) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 5 / 7 | ASP A 56GLY A 301ASP A 346HIS A 308ASP A 304 | ZN A1476 (-2.2A) MG A1477 ( 4.5A) ZN A1476 (-2.3A) ZN A1475 ( 3.2A) ZN A1475 ( 2.0A) | 1.45A | 5nnwD-2x98A:undetectable | 5nnwD-2x98A:12.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NO9_D_95ZD302_1 (25 KDA PROTEINELICITOR) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 5 / 7 | ASP A 56GLY A 301ASP A 346HIS A 308ASP A 304 | ZN A1476 (-2.2A) MG A1477 ( 4.5A) ZN A1476 (-2.3A) ZN A1475 ( 3.2A) ZN A1475 ( 2.0A) | 1.49A | 5no9D-2x98A:undetectable | 5no9D-2x98A:12.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5O4Y_D_CCSD14_0 (PHE-MAA-ASN-PRO-HIS-LEU-SER-TRP-SER-TRP-9KK-9KK-ARG-CCS-GLY-NH2PROGRAMMED CELLDEATH 1 LIGAND 1) |
1htq | GLUTAMINE SYNTHETASE (Mycobacteriumtuberculosis) | 5 / 12 | LEU A 322GLY A 265GLU A 131GLY A 267ARG A 359 | NoneCIT A7476 (-3.2A)CIT A7476 (-2.7A)CIT A7476 (-3.8A) MN A 470 (-3.4A) | 1.20A | 5o4yD-1htqA:undetectable5o4yE-1htqA:0.0 | 5o4yD-1htqA:20.005o4yE-1htqA:13.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5O96_A_SAMA501_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE E) |
1rbl | RIBULOSE 1,5BISPHOSPHATECARBOXYLASE/OXYGENASE (LARGE CHAIN) (Synechococcuselongatus) | 5 / 11 | LEU A 326GLY A 329LEU A 318ARG A 312ALA A 315 | NoneCAP A 476 ( 4.3A)NoneNoneNone | 1.13A | 5o96A-1rblA:undetectable5o96B-1rblA:3.5 | 5o96A-1rblA:20.445o96B-1rblA:20.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5SXQ_B_NIZB808_1 (CATALASE-PEROXIDASE) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 4 / 8 | GLU A 287GLU A 173GLY A 78THR A 81 | IF6 A1476 (-1.9A)IF6 A1476 (-3.1A)NoneNone | 1.05A | 5sxqB-5g0qA:undetectable | 5sxqB-5g0qA:22.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5SYJ_A_NIZA809_1 (CATALASE-PEROXIDASE) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 4 / 8 | GLU A 287GLU A 173GLY A 78THR A 81 | IF6 A1476 (-1.9A)IF6 A1476 (-3.1A)NoneNone | 1.04A | 5syjA-5g0qA:undetectable | 5syjA-5g0qA:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNS_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 5unsA-5fjnA:undetectable5unsB-5fjnA:undetectable | 5unsA-5fjnA:23.275unsB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNS_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 5unsA-5fjnA:undetectable5unsB-5fjnA:undetectable | 5unsA-5fjnA:23.275unsB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNT_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 5untA-5fjnA:undetectable5untB-5fjnA:undetectable | 5untA-5fjnA:23.275untB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNT_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.28A | 5untA-5fjnA:undetectable5untB-5fjnA:undetectable | 5untA-5fjnA:23.275untB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNZ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 5unzA-5fjnA:undetectable5unzB-5fjnA:undetectable | 5unzA-5fjnA:23.275unzB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO2_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 5uo2A-5fjnA:undetectable5uo2B-5fjnA:undetectable | 5uo2A-5fjnA:23.665uo2B-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO2_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.28A | 5uo2A-5fjnA:undetectable5uo2B-5fjnA:undetectable | 5uo2A-5fjnA:23.665uo2B-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO3_B_H4BB803_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 5uo3A-5fjnA:undetectable5uo3B-5fjnA:undetectable | 5uo3A-5fjnA:23.665uo3B-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO4_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 5uo4A-5fjnA:undetectable5uo4B-5fjnA:undetectable | 5uo4A-5fjnA:23.665uo4B-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO7_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 8 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.30A | 5uo7A-5fjnA:undetectable5uo7B-5fjnA:undetectable | 5uo7A-5fjnA:23.665uo7B-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUN_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.33A | 5vunA-5fjnA:undetectable5vunB-5fjnA:undetectable | 5vunA-5fjnA:23.275vunB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUN_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 5vunA-5fjnA:undetectable5vunB-5fjnA:undetectable | 5vunA-5fjnA:23.275vunB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUO_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.35A | 5vuoA-5fjnA:undetectable5vuoB-5fjnA:undetectable | 5vuoA-5fjnA:23.275vuoB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUP_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 5vupA-5fjnA:undetectable5vupB-5fjnA:undetectable | 5vupA-5fjnA:23.275vupB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUT_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 5vutA-5fjnA:undetectable5vutB-5fjnA:undetectable | 5vutA-5fjnA:23.275vutB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUT_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.32A | 5vutA-5fjnA:undetectable5vutB-5fjnA:undetectable | 5vutA-5fjnA:23.275vutB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUU_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 5vuuA-5fjnA:undetectable5vuuB-5fjnA:undetectable | 5vuuA-5fjnA:23.275vuuB-5fjnA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUW_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 5vuwA-5fjnA:undetectable5vuwB-5fjnA:undetectable | 5vuwA-5fjnA:23.665vuwB-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV1_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 6 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.36A | 5vv1A-5fjnA:undetectable5vv1B-5fjnA:undetectable | 5vv1A-5fjnA:23.665vv1B-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV2_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.34A | 5vv2A-5fjnA:undetectable5vv2B-5fjnA:undetectable | 5vv2A-5fjnA:23.665vv2B-5fjnA:23.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_A_ACRA1431_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
3nxl | GLUCARATEDEHYDRATASE (Burkholderialata) | 4 / 7 | ASN A 309ASP A 281GLY A 228ASN A 257 | MG A 476 (-2.4A)NoneNone MG A 476 ( 4.3A) | 1.13A | 5x7pA-3nxlA:undetectable | 5x7pA-3nxlA:17.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_A_ACRA1431_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
3nxl | GLUCARATEDEHYDRATASE (Burkholderialata) | 4 / 7 | HIS A 36ASP A 255GLY A 228ASN A 31 | CO3 A 477 (-4.0A) MG A 476 (-2.8A)NoneCO3 A 477 ( 3.8A) | 1.12A | 5x7pA-3nxlA:undetectable | 5x7pA-3nxlA:17.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_B_ACRB1431_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
3nxl | GLUCARATEDEHYDRATASE (Burkholderialata) | 4 / 5 | HIS A 36ASP A 255GLY A 228ASN A 31 | CO3 A 477 (-4.0A) MG A 476 (-2.8A)NoneCO3 A 477 ( 3.8A) | 1.12A | 5x7pB-3nxlA:undetectable | 5x7pB-3nxlA:17.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIQ_A_HFGA1002_0 (PROLYL-TRNASYNTHETASE (PRORS)) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 5 / 12 | LEU A 176GLU A 245GLU A 45SER A 43GLY A 328 | NoneNoneIF6 A1476 (-2.9A)NoneNone | 1.26A | 5xiqA-5g0qA:undetectable | 5xiqA-5g0qA:20.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUQ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 6auqA-5fjnA:undetectable6auqB-5fjnA:undetectable | 6auqA-5fjnA:10.966auqB-5fjnA:10.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUR_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 6aurA-5fjnA:undetectable6aurB-5fjnA:undetectable | 6aurA-5fjnA:10.966aurB-5fjnA:10.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUR_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.33A | 6aurA-5fjnA:undetectable6aurB-5fjnA:undetectable | 6aurA-5fjnA:10.966aurB-5fjnA:10.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUS_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.30A | 6ausA-5fjnA:undetectable6ausB-5fjnA:undetectable | 6ausA-5fjnA:10.966ausB-5fjnA:10.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUS_B_H4BB803_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 6ausA-5fjnA:undetectable6ausB-5fjnA:undetectable | 6ausA-5fjnA:10.966ausB-5fjnA:10.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUT_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.27A | 6autA-5fjnA:undetectable6autB-5fjnA:undetectable | 6autA-5fjnA:10.966autB-5fjnA:10.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUU_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.26A | 6auuA-5fjnA:undetectable6auuB-5fjnA:undetectable | 6auuA-5fjnA:10.966auuB-5fjnA:10.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUV_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.33A | 6auvA-5fjnA:undetectable6auvB-5fjnA:undetectable | 6auvA-5fjnA:10.966auvB-5fjnA:10.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUV_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 6auvA-5fjnA:undetectable6auvB-5fjnA:undetectable | 6auvA-5fjnA:10.966auvB-5fjnA:10.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUW_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.34A | 6auwA-5fjnA:undetectable6auwB-5fjnA:undetectable | 6auwA-5fjnA:10.966auwB-5fjnA:10.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUX_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.28A | 6auxA-5fjnA:undetectable6auxB-5fjnA:undetectable | 6auxA-5fjnA:10.966auxB-5fjnA:10.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUX_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.28A | 6auxA-5fjnA:undetectable6auxB-5fjnA:undetectable | 6auxA-5fjnA:10.966auxB-5fjnA:10.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUY_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 6auyA-5fjnA:undetectable6auyB-5fjnA:undetectable | 6auyA-5fjnA:9.616auyB-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUY_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.30A | 6auyA-5fjnA:undetectable6auyB-5fjnA:undetectable | 6auyA-5fjnA:9.616auyB-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUZ_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.28A | 6auzA-5fjnA:undetectable6auzB-5fjnA:undetectable | 6auzA-5fjnA:9.616auzB-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUZ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 6auzA-5fjnA:undetectable6auzB-5fjnA:undetectable | 6auzA-5fjnA:9.616auzB-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV0_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.33A | 6av0A-5fjnA:undetectable6av0B-5fjnA:undetectable | 6av0A-5fjnA:9.616av0B-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV0_B_H4BB803_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.26A | 6av0A-5fjnA:undetectable6av0B-5fjnA:undetectable | 6av0A-5fjnA:9.616av0B-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV2_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 6av2A-5fjnA:undetectable6av2B-5fjnA:undetectable | 6av2A-5fjnA:9.616av2B-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV2_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.27A | 6av2A-5fjnA:undetectable6av2B-5fjnA:undetectable | 6av2A-5fjnA:9.616av2B-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV3_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 6av3A-5fjnA:undetectable6av3B-5fjnA:undetectable | 6av3A-5fjnA:9.616av3B-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV4_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.32A | 6av4A-5fjnA:undetectable6av4B-5fjnA:undetectable | 6av4A-5fjnA:9.616av4B-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV4_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.27A | 6av4A-5fjnA:undetectable6av4B-5fjnA:undetectable | 6av4A-5fjnA:9.616av4B-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV5_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.31A | 6av5A-5fjnA:undetectable6av5B-5fjnA:undetectable | 6av5A-5fjnA:9.616av5B-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV5_B_H4BB803_1 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.29A | 6av5A-5fjnA:undetectable6av5B-5fjnA:undetectable | 6av5A-5fjnA:9.616av5B-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CIC_A_H4BA802_0 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.33A | 6cicA-5fjnA:undetectable6cicB-5fjnA:undetectable | 6cicA-5fjnA:9.616cicB-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CIC_B_H4BB802_0 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 6cicA-5fjnA:undetectable6cicB-5fjnA:undetectable | 6cicA-5fjnA:9.616cicB-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CID_A_H4BA802_0 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | ARG A 316VAL A 438TRP A 439GLU A 418 | BE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A)None | 1.33A | 6cidA-5fjnA:undetectable6cidB-5fjnA:undetectable | 6cidA-5fjnA:9.616cidB-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CID_B_H4BB803_0 (NITRIC OXIDESYNTHASE, BRAIN) |
5fjn | L-AMINO ACIDDEAMINASE (Cosenzaeamyxofaciens) | 4 / 7 | GLU A 418ARG A 316VAL A 438TRP A 439 | NoneBE2 A1476 (-4.0A)BE2 A1476 ( 4.3A)BE2 A1476 ( 3.7A) | 1.31A | 6cidA-5fjnA:undetectable6cidB-5fjnA:undetectable | 6cidA-5fjnA:9.616cidB-5fjnA:9.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FGD_A_ACTA806_0 (GEPHYRIN) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 4 / 4 | MET A 58GLY A 57HIS A 347GLY A 59 | NoneNone ZN A1476 ( 3.1A)None | 1.36A | 6fgdA-2x98A:undetectable | 6fgdA-2x98A:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FGD_A_ACTA806_0 (GEPHYRIN) |
2x98 | ALKALINE PHOSPHATASE (Halobacteriumsalinarum) | 4 / 4 | MET A 58GLY A 57HIS A 347GLY A 345 | NoneNone ZN A1476 ( 3.1A)None | 0.99A | 6fgdA-2x98A:undetectable | 6fgdA-2x98A:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_A_ZOLA401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 6 / 7 | ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) | 1.04A | 6g31A-4jzxA:25.3 | 6g31A-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_B_ZOLB401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 6 | ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) | 0.83A | 6g31B-4jzxA:25.2 | 6g31B-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_C_ZOLC401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 4 / 5 | ASP A 98ASP A 102ARG A 107LYS A 207 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-2.7A) | 1.12A | 6g31C-4jzxA:25.6 | 6g31C-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_C_ZOLC401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 4 / 5 | ASP A 98ASP A 102GLN A 167LYS A 207 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-3.5A)476 A 402 (-2.7A) | 1.11A | 6g31C-4jzxA:25.6 | 6g31C-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_D_ZOLD401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 6 / 7 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) | 0.67A | 6g31D-4jzxA:24.9 | 6g31D-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_E_ZOLE401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 4 / 4 | LEU A 95ASP A 98ASP A 102ARG A 107 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A) | 0.45A | 6g31E-4jzxA:19.3 | 6g31E-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_F_ZOLF401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 5 | ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) | 0.89A | 6g31F-4jzxA:25.4 | 6g31F-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_G_ZOLG401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 6 / 7 | ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207GLN A 247 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) | 0.82A | 6g31G-4jzxA:24.3 | 6g31G-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_H_ZOLH401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 4 / 5 | ASP A 98ASP A 102GLN A 167GLN A 247 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-3.5A)IPE A 401 (-3.7A) | 0.59A | 6g31H-4jzxA:24.3 | 6g31H-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_I_ZOLI401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 4 / 4 | ASP A 98ASP A 102LYS A 207GLN A 247 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.7A)IPE A 401 (-3.7A) | 0.96A | 6g31I-4jzxA:24.2 | 6g31I-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_J_ZOLJ401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 6 / 6 | LEU A 95ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247 | None CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) | 1.01A | 6g31J-4jzxA:25.7 | 6g31J-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_K_ZOLK401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 4 / 4 | ASP A 98ASP A 102ARG A 107GLN A 167 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A) | 0.63A | 6g31K-4jzxA:23.3 | 6g31K-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_L_ZOLL401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 5 / 6 | ASP A 98ASP A 102ARG A 107GLN A 167GLN A 247 | CA A 403 (-2.5A) CA A 403 (-2.5A)476 A 402 (-2.9A)476 A 402 (-3.5A)IPE A 401 (-3.7A) | 1.07A | 6g31L-4jzxA:25.2 | 6g31L-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_L_ZOLL401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
4jzx | FARNESYLPYROPHOSPHATESYNTHASE (Leishmaniamajor) | 4 / 6 | ASP A 98GLN A 167GLN A 247LYS A 273 | CA A 403 (-2.5A)476 A 402 (-3.5A)IPE A 401 (-3.7A) CA A 403 ( 4.9A) | 1.34A | 6g31L-4jzxA:25.2 | 6g31L-4jzxA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GNE_A_ACRA602_2 (-) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 4 / 6 | TYR A 334HIS A 241TYR A 292GLU A 268 | IF6 A1476 (-4.4A)NoneIF6 A1476 (-4.0A)None | 1.27A | 6gneA-5g0qA:undetectable | 6gneA-5g0qA:21.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GNE_B_ACRB602_2 (-) |
5g0q | BETA-GLUCURONIDASE (Acidobacteriumcapsulatum) | 4 / 8 | TYR A 334HIS A 241TYR A 292GLU A 268 | IF6 A1476 (-4.4A)NoneIF6 A1476 (-4.0A)None | 1.27A | 6gneB-5g0qA:undetectable | 6gneB-5g0qA:21.83 |